{"altmetric_id":15375434,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["who"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4e93cf058f610002446","authors":["Colette Adida","Christian Recher","Emmanuel Raffoux","Marie-Therese Daniel","Anne-Laure Taksin","Philippe Rousselot","Francois Sigaux","Laurent Degos","Dario C. Altieri","Herve Dombret"],"doi":"10.1046\/j.1365-2141.2000.02328.x","endpage":"203","first_seen_on":"2017-01-11T01:32:19+00:00","issns":["0007-1048","1365-2141"],"issue":"1","journal":"British Journal of Haematology","last_mentioned_on":1325376000,"links":["http:\/\/dx.doi.org\/10.1046\/j.1365-2141.2000.02328.x"],"pubdate":"2000-10-01T00:00:00+00:00","publisher_subjects":[{"name":"Cardiovascular Medicine And Haematology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"196","title":"Expression and prognostic significance of survivin in de novo acute myeloid leukaemia","type":"article","volume":"111","mendeley_url":"http:\/\/www.mendeley.com\/research\/expression-prognostic-significance-survivin-novo-acute-myeloid-leukaemia-2"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":6939019,"mean":6.2245338078075,"rank":1619659,"this_scored_higher_than_pct":65,"this_scored_higher_than":4533346,"rank_type":"exact","sample_size":6939019,"percentile":65},"similar_age_3m":{"total_number_of_other_articles":94143,"mean":10.906991969578,"rank":28245,"this_scored_higher_than_pct":68,"this_scored_higher_than":64615,"rank_type":"exact","sample_size":94143,"percentile":68},"this_journal":{"total_number_of_other_articles":1987,"mean":2.6228197381672,"rank":253,"this_scored_higher_than_pct":63,"this_scored_higher_than":1263,"rank_type":"exact","sample_size":1987,"percentile":63},"similar_age_this_journal_3m":{"total_number_of_other_articles":28,"mean":5.6574074074074,"rank":7,"this_scored_higher_than_pct":71,"this_scored_higher_than":20,"rank_type":"exact","sample_size":28,"percentile":71}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor":2},"by_discipline":{"Medicine and Dentistry":1,"Unspecified":1}}}},"posts":{"policy":[{"title":"Growth advantage of CD34+ cells in trisomy 8 high-risk myelodysplastic syndrome despite enhanced apoptotic signals","url":"http:\/\/apps.who.int\/iris\/bitstream\/10665\/118509\/1\/2012_18_10_1065_1071.pdf","license":"public","citation_ids":[15375424,15375426,15375430,3502034,15375434,15375438,15375441,15375446,15375451,15375456,12050071,15375467,15375472,15375475,15375477],"posted_on":"2012-01-01T00:00:00+00:00","source":{"name":"World Health Organization","description":"The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.","geo":{"country":"CH"}},"page_url":"http:\/\/apps.who.int\/iris\/handle\/10665\/118509","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-cb2d75043e74bfc2ee319e29192990c3a2ed6a8d7e6f9419f8957a3a96dcc34a.jpg"}}]}}